NICE National Institute for Health and Care Excellence WFSBP World Federation of
Societies of Biological Psychiatry FDA Food and Drug Administration DLPFC dorzolaterális …

Hypoactivity of the dorsolateral prefrontal cortex (dlPFC) has been described as a
pathophysiological characteristic of major depression disorder (MDD)[1] which is associated …

Depressive disorders belong to the most frequent psychiatric disorders in Western Europe
and the USA and are associated with high recurrence rates, high resistance to therapy …

AbstracttDCS is a low-cost and well-tolerated neuromodulation treatment of depression. It
seems to be a good and effective option to start the treatment of depression along or instead …

Objective The aim of the study was comparative assessment of efficiency of combined TMS
included treatment of pharmaco-resistant depression upon reduction of clinical symptoms …

Repetitive transcranial magnetic stimulation (rTMS) treatment is increasingly a standard part
of the management of patients with depression supported by a rapidly expanding research …

Treatment-resistant depression (TRD) is a major public health problem, affecting patients,
their close relatives, and the society as a whole. Despite recent developments in …

In this literature review the new trends of cognitive behavioural therapy (CBT), namely
behavioural activation and rumination-focused cognitive behavioural therapy are introduced …

With interest we took notice of the article by Goldman and colleagues, describing age as a
(non) determinant of effectiveness in treating major depressive disorder (MDD) with …

Aims rTMS (Repetitive transcranial magnetic stimulation) as a brain stimulation modality is
approved to treat treatment-resistant depression. Its efficacy in depression and anxiety is …